MDGL Insider Trading

Insider Trading Chart
Insider Trading History
Frequently Asked Questions
About

Insider Ownership Percentage: 22.80%

Insider Buying (Last 12 Months): $0.00

Insider Selling (Last 12 Months): $23,679,531.36

Madrigal Pharmaceuticals Insider Trading History Chart

Madrigal Pharmaceuticals Share Price & Price History

^$295.02

▼ -6.64 (-2.20%)

As of 04/21/2025 05:00 PM ET

Days: 30 | 90 | 365

Madrigal Pharmaceuticals Insider Trading History

Transaction Date	Insider Name	Title	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
3/5/2025	Robert E. Waltermire	VP	Sell	14,113	$341.32	$4,817,049.16	3,728
2/28/2025	Robert E. Waltermire	VP	Sell	1,227	$341.07	$418,492.89	3,728
2/27/2025	James M. Daly	Director	Sell	15,470	$347.45	$5,375,051.50	1,912
1/24/2025	Carole Huntsman	Insider	Sell	347	$335.24	$116,328.28	10,438
1/24/2025	Rebecca Taub	CMO	Sell	648	$335.24	$217,235.52	456,662
1/24/2025	Robert E. Waltermire	VP	Sell	103	$335.24	$34,529.72	4,955
1/24/2025	William John Sibold	CEO	Sell	1,584	$335.24	$531,020.16	54,303
1/17/2025	Rebecca Taub	CMO	Sell	1,689	$273.41	$461,789.49	457,310
1/17/2025	Robert E. Waltermire	VP	Sell	442	$273.41	$120,847.22	5,058
1/17/2025	Shannon T. Kelley	General Counsel	Sell	277	$273.41	$75,734.57	7,705
12/3/2024	Fred B. Craves	Director	Sell	3,600	$315.31	$1,135,116.00	11,000
11/25/2024	Fred B. Craves	Director	Sell	3,400	$350.30	$1,191,020.00	14,600
11/1/2024	Richard S. Levy	Director	Sell	5,000	$300.94	$1,504,700.00	11,012
9/9/2024	William John Sibold	CEO	Sell	6,363	$243.83	$1,551,490.29	55,887
6/14/2024	Robert E. Waltermire	VP	Sell	1,900	$280.00	$532,000.00	5,500
6/12/2024	Robert E. Waltermire	VP	Sell	2,000	$285.00	$570,000.00	5,500
5/21/2024	Robert E. Waltermire	VP	Sell	1,036	$231.34	$239,668.24	5,500
5/14/2024	Fred B. Craves	Director	Sell	22,489	$212.88	$4,787,458.32	413,362
4/8/2024	Paul A. Friedman	Director	Sell	26,270	$246.19	$6,467,411.30	185,735
4/8/2024	Rebecca Taub	CMO	Sell	2,676	$245.99	$658,269.24	458,999
4/5/2024	Rebecca Taub	CMO	Sell	27,506	$243.36	$6,693,860.16	458,999
4/4/2024	Paul A. Friedman	Director	Sell	18,710	$242.96	$4,545,781.60	185,735
4/3/2024	Rebecca Taub	CMO	Sell	27,845	$245.14	$6,825,923.30	458,999
4/1/2024	James M. Daly	Director	Sell	32,489	$102.77	$3,338,894.53	1,198
4/1/2024	Richard S. Levy	Director	Sell	11,000	$257.48	$2,832,280.00	10,298
12/13/2023	Bros. Advisors Lp Baker	Director	Buy	81,159	$219.39	$17,805,473.01	1,774,294
12/13/2023	Robert E. Waltermire	VP	Sell	2,500	$225.40	$563,500.00	5,667
12/4/2023	Brian Joseph Lynch	SVP	Sell	1,800	$218.87	$393,966.00	15,001
11/29/2023	Brian Joseph Lynch	SVP	Sell	4,000	$199.19	$796,760.00	15,001
11/21/2023	Bros. Advisors Lp Baker	Director	Buy	64,350	$188.47	$12,128,044.50	1,667,104
11/17/2023	Bros. Advisors Lp Baker	Director	Buy	46,370	$174.70	$8,100,839.00	1,588,541
11/14/2023	Bros. Advisors Lp Baker	Director	Buy	34,188	$156.42	$5,347,686.96	1,531,757
1/17/2023	Richard S. Levy	Director	Sell	22,489	$293.15	$6,592,650.35	9,100
1/3/2023	Brian Joseph Lynch	SVP	Sell	13,000	$282.92	$3,677,960.00
12/23/2022	Brian Joseph Lynch	SVP	Sell	7,000	$274.18	$1,919,260.00
12/23/2022	Remy Sukhija	insider	Sell	30,000	$274.14	$8,224,200.00

See Full Table

SEC Filings (Institutional Ownership Changes) for Madrigal Pharmaceuticals (NASDAQ:MDGL)

98.50% of Madrigal Pharmaceuticals stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

Madrigal Pharmaceuticals Institutional Trading History

Reporting Date	Hedge Fund	Shares Held	Market Value	% of Portfolio	Quarterly Change in Shares	Ownership in Company
4/17/2025	QRG Capital Management Inc.	726	$0.24M	0.0%	N/A	0.003%
4/15/2025	Kozak & Associates Inc.	324	$0.10M	0.0%	N/A	0.001%
4/15/2025	Handelsbanken Fonder AB	4,800	$1.59M	0.0%	-85.4%	0.022%
4/15/2025	GAMMA Investing LLC	118	$39K	0.0%	+131.4%	0.001%
4/14/2025	Farther Finance Advisors LLC	111	$36K	0.0%	+825.0%	0.001%
4/14/2025	Rheos Capital Works Inc.	43,215	$14.31M	1.2%	-23.1%	0.196%
4/14/2025	Park Avenue Securities LLC	656	$0.22M	0.0%	N/A	0.003%
4/10/2025	Hennion & Walsh Asset Management Inc.	11,009	$3.65M	0.2%	+11.2%	0.050%
4/8/2025	Rhumbline Advisers	26,364	$8.73M	0.0%	+7.9%	0.119%
4/8/2025	Parallel Advisors LLC	284	$94K	0.0%	+42.7%	0.001%
4/7/2025	GAMMA Investing LLC	39,085	$12.95M	0.0%	+76,537.3%	0.177%
3/24/2025	Wellington Management Group LLP	8,172	$2.52M	0.0%	-9.5%	0.037%
3/18/2025	California State Teachers Retirement System	12,546	$3.87M	0.0%	+0.8%	0.057%
3/17/2025	Wealth Enhancement Advisory Services LLC	680	$0.21M	0.0%	N/A	0.003%
3/12/2025	Centaurus Financial Inc.	690	$0.21M	0.0%	+12.9%	0.003%
2/19/2025	GF Fund Management CO. LTD.	458	$0.14M	0.0%	N/A	0.002%
2/17/2025	UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC	27,538	$8.50M	0.0%	+23.2%	0.126%
2/17/2025	Woodline Partners LP	309,117	$95.38M	0.6%	+110.2%	1.417%
2/17/2025	Vestal Point Capital LP	95,000	$29.31M	1.7%	+216.7%	0.436%
2/17/2025	Soleus Capital Management L.P.	10,900	$3.36M	0.2%	N/A	0.050%
2/17/2025	Tema Etfs LLC	3,620	$1.12M	0.5%	N/A	0.017%
2/17/2025	Snowden Capital Advisors LLC	1,905	$0.59M	0.0%	+23.8%	0.009%
2/17/2025	Rafferty Asset Management LLC	33,123	$10.22M	0.0%	-25.8%	0.152%
2/17/2025	Polar Capital Holdings Plc	137,720	$42.50M	0.2%	+37.1%	0.631%
2/17/2025	ProShare Advisors LLC	6,096	$1.88M	0.0%	+32.6%	0.028%
2/17/2025	Man Group plc	8,498	$2.62M	0.0%	N/A	0.039%
2/17/2025	Nuveen Asset Management LLC	77,869	$24.03M	0.0%	-12.5%	0.357%
2/17/2025	MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd.	14,162	$4.37M	0.0%	+1.0%	0.065%
2/17/2025	Janus Henderson Group PLC	2,208,394	$681.37M	0.3%	-10.9%	10.126%
2/17/2025	Graham Capital Management L.P.	659	$0.20M	0.0%	N/A	0.003%
2/17/2025	Ensign Peak Advisors Inc	35,361	$10.91M	0.0%	+124.7%	0.162%
2/17/2025	FORA Capital LLC	1,123	$0.35M	0.0%	N/A	0.005%
2/17/2025	Deutsche Bank AG	43,658	$13.47M	0.0%	-10.8%	0.200%
2/17/2025	Cetera Investment Advisers	2,882	$0.89M	0.0%	+85.5%	0.013%
2/17/2025	Brevan Howard Capital Management LP	1,001	$0.31M	0.0%	N/A	0.005%
2/17/2025	Bridgefront Capital LLC	1,084	$0.33M	0.1%	N/A	0.005%
2/17/2025	Bayesian Capital Management LP	3,573	$1.10M	0.1%	+137.9%	0.016%
2/17/2025	Bank of America Corp DE	217,828	$67.22M	0.0%	+1.4%	0.999%
2/17/2025	BNP Paribas Financial Markets	6,921	$2.14M	0.0%	-29.1%	0.032%
2/17/2025	Ameriprise Financial Inc.	8,668	$2.68M	0.0%	-77.0%	0.040%
2/17/2025	Algert Global LLC	9,770	$3.02M	0.1%	N/A	0.045%
2/17/2025	ArrowMark Colorado Holdings LLC	199,667	$61.61M	0.8%	+23.3%	0.915%
2/14/2025	Schonfeld Strategic Advisors LLC	5,525	$1.71M	0.0%	-88.0%	0.025%
2/14/2025	Emerald Mutual Fund Advisers Trust	18,656	$5.76M	0.4%	-14.0%	0.086%
2/14/2025	Northern Trust Corp	155,883	$48.10M	0.0%	+5.5%	0.715%
2/14/2025	The Manufacturers Life Insurance Company	24,080	$7.43M	0.0%	-19.6%	0.110%
2/14/2025	Tudor Investment Corp ET AL	10,327	$3.19M	0.0%	-837.6%	0.047%
2/14/2025	Tri Locum Partners LP	47,472	$14.65M	3.0%	+9.7%	0.218%
2/14/2025	Aquatic Capital Management LLC	15,032	$4.64M	0.1%	N/A	0.069%
2/14/2025	Virtus ETF Advisers LLC	1,156	$0.36M	0.1%	-2.8%	0.005%
2/14/2025	Gilder Gagnon Howe & Co. LLC	36,168	$11.16M	0.1%	-5.2%	0.166%
2/14/2025	Lord Abbett & CO. LLC	48,917	$15.10M	0.0%	N/A	0.224%
2/14/2025	Voya Investment Management LLC	9,942	$3.07M	0.0%	-77.2%	0.046%
2/14/2025	Adage Capital Partners GP L.L.C.	19,960	$6.16M	0.0%	N/A	0.092%
2/14/2025	Syon Capital LLC	1,014	$0.31M	0.0%	N/A	0.005%
2/14/2025	Hood River Capital Management LLC	127,839	$39.45M	0.6%	N/A	0.586%
2/14/2025	Price T Rowe Associates Inc. MD	588,764	$181.68M	0.0%	-19.8%	2.700%
2/14/2025	Dark Forest Capital Management LP	1,286	$0.40M	0.1%	N/A	0.006%
2/14/2025	Hsbc Holdings PLC	2,091	$0.64M	0.0%	+32.7%	0.010%
2/14/2025	Rock Springs Capital Management LP	265,212	$81.84M	3.1%	+0.8%	1.216%
2/14/2025	J. Safra Sarasin Holding AG	3,405	$1.05M	0.0%	-39.2%	0.016%
2/14/2025	Stifel Financial Corp	2,598	$0.80M	0.0%	-4.0%	0.012%
2/14/2025	Tower Research Capital LLC TRC	3,026	$0.93M	0.0%	+790.0%	0.014%
2/14/2025	MetLife Investment Management LLC	10,818	$3.34M	0.0%	+6.9%	0.050%
2/14/2025	Nan Fung Group Holdings Ltd	11,122	$3.43M	2.9%	+13.9%	0.051%
2/14/2025	BI Asset Management Fondsmaeglerselskab A S	531	$0.16M	0.0%	N/A	0.002%
2/14/2025	First Trust Advisors LP	4,014	$1.24M	0.0%	+50.8%	0.018%
2/13/2025	CANADA LIFE ASSURANCE Co	2,334	$0.72M	0.0%	+81.1%	0.011%
2/13/2025	Canada Pension Plan Investment Board	13,400	$4.14M	0.0%	N/A	0.061%
2/13/2025	Farringdon Capital Ltd.	697	$0.22M	0.1%	N/A	0.003%
2/13/2025	Marshall Wace LLP	17,494	$5.40M	0.0%	-78.2%	0.080%
2/13/2025	Affinity Asset Advisors LLC	82,500	$25.46M	3.4%	-17.5%	0.378%
2/13/2025	Jump Financial LLC	682	$0.21M	0.0%	N/A	0.003%
2/13/2025	Guggenheim Capital LLC	2,668	$0.82M	0.0%	-26.8%	0.012%
2/13/2025	Rossby Financial LCC	1,048	$0.32M	0.2%	N/A	0.005%
2/13/2025	Mariner LLC	1,746	$0.54M	0.0%	-41.8%	0.008%
2/13/2025	Barclays PLC	53,253	$16.43M	0.0%	+32.2%	0.244%
2/13/2025	University of Wisconsin Foundation	41,541	$12.82M	9.3%	-9.2%	0.190%
2/13/2025	Summit Investment Advisors Inc.	1,881	$0.58M	0.5%	+5.9%	0.009%
2/13/2025	Rockefeller Capital Management L.P.	18,210	$5.62M	0.0%	+0.7%	0.083%
2/13/2025	F M Investments LLC	2,259	$0.70M	0.0%	N/A	0.010%
2/13/2025	Raymond James Financial Inc.	53,846	$16.62M	0.0%	N/A	0.247%
2/13/2025	Martingale Asset Management L P	5,914	$1.83M	0.0%	+2.6%	0.027%
2/13/2025	Capula Management Ltd	1,148	$0.35M	0.0%	N/A	0.005%
2/13/2025	Renaissance Technologies LLC	160,782	$49.61M	0.1%	+261.3%	0.737%
2/13/2025	Legal & General Group Plc	14,463	$4.46M	0.0%	-2.1%	0.066%
2/13/2025	Invesco Ltd.	129,074	$39.83M	0.0%	+7.3%	0.592%
2/13/2025	Cerity Partners LLC	1,467	$0.45M	0.0%	N/A	0.007%
2/13/2025	FMR LLC	867,850	$267.79M	0.0%	+10.8%	3.979%
2/13/2025	Russell Investments Group Ltd.	1,482	$0.46M	0.0%	+120.2%	0.007%
2/13/2025	Envestnet Asset Management Inc.	15,001	$4.63M	0.0%	+2.3%	0.069%
2/13/2025	Wells Fargo & Company MN	34,923	$10.78M	0.0%	+19.1%	0.160%
2/12/2025	Landscape Capital Management L.L.C.	3,624	$1.12M	0.1%	N/A	0.017%
2/12/2025	Pitcairn Co.	1,060	$0.33M	0.0%	+3.2%	0.005%
2/12/2025	Cinctive Capital Management LP	5,406	$1.67M	0.1%	+6.5%	0.025%
2/12/2025	Bryce Point Capital LLC	1,903	$0.59M	0.2%	N/A	0.009%
2/12/2025	Groupama Asset Managment	24,324	$7.58M	0.1%	+89.5%	0.112%
2/12/2025	Geode Capital Management LLC	410,578	$126.72M	0.0%	+1.2%	1.883%
2/12/2025	Franklin Resources Inc.	6,087	$1.88M	0.0%	+340.1%	0.028%
2/12/2025	Alliancebernstein L.P.	37,772	$11.66M	0.0%	-16.3%	0.173%

Data available starting January 2016

See Full Table

Madrigal Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the development of therapeutics for the treatment of non-alcoholic steatohepatitis (NASH) in the United States. Its lead product candidate is resmetirom, a liver-directed thyroid hormone receptor beta agonist, which is in Phase 3 clinical trials for treating NASH. The company is headquartered in West Conshohocken, Pennsylvania.

Today's Range

Now: $295.02

$276.20

$300.85

50 Day Range

MA: $328.07

$295.02

$355.88

52 Week Range

Now: $295.02

$189.00

$377.46

Volume

516,782 shs

Average Volume

391,289 shs

Market Capitalization

$6.51 billion

P/E Ratio

N/A

Dividend Yield

N/A

Beta

N/A

Who are the company insiders with the largest holdings of Madrigal Pharmaceuticals?: Madrigal Pharmaceuticals' top insider investors include:
Bros Advisors Lp Baker (Director)
Rebecca Taub (CMO)
Fred B Craves (Director)
Paul A Friedman (Director)
William John Sibold (CEO)
Brian Joseph Lynch (SVP)
Richard S Levy (Director)
Carole Huntsman (Insider)
Shannon T Kelley (General Counsel)
Robert E Waltermire (VP)
James M Daly (Director)
Learn More about top insider investors at Madrigal Pharmaceuticals.
Who are the major institutional investors of Madrigal Pharmaceuticals?: Madrigal Pharmaceuticals' top institutional shareholders include:
Rheos Capital Works Inc. — 0.20%
GAMMA Investing LLC — 0.18%
Rhumbline Advisers — 0.12%
Hennion & Walsh Asset Management Inc. — 0.05%
Handelsbanken Fonder AB — 0.02%
QRG Capital Management Inc. — 0.00%
Learn More about top institutional investors of Madrigal Pharmaceuticals stock.
Which major investors are selling Madrigal Pharmaceuticals stock?: During the last quarter, MDGL stock was sold by these institutional investors:
Handelsbanken Fonder AB
Rheos Capital Works Inc.
Within the previous year, company insiders that have sold Madrigal Pharmaceuticals company stock include:
Bros Advisors Lp Baker (Director)
Rebecca Taub (CMO)
Fred B Craves (Director)
Paul A Friedman (Director)
William John Sibold (CEO)
Brian Joseph Lynch (SVP)
Richard S Levy (Director)
Carole Huntsman (Insider)
Learn More investors selling Madrigal Pharmaceuticals stock.
Which major investors are buying Madrigal Pharmaceuticals stock?: Within the last quarter, MDGL stock was purchased by institutional investors including:
GAMMA Investing LLC
Rhumbline Advisers
Hennion & Walsh Asset Management Inc.
QRG Capital Management Inc.
Park Avenue Securities LLC
Kozak & Associates Inc.
Farther Finance Advisors LLC
Parallel Advisors LLC